Abstract
Purpose
A panel of Japanese experts on tumor ablation therapy gathered to reach a general consensus on topics surrounding ablation therapy.
Materials and methods
Questionnaires relating to ablation protocols for radiofrequency ablation (RFA) and cryoablation, as well as ancillary procedures required for safe and secure ablation therapy, were sent to seven institutions. Experts from these institutions discussed each topic based on the evidence and the questionnaire data, and a consensus was reached at an annual meeting of the Japan Image-guided Ablation Group in Maebashi, Japan, in October 2015.
Results
A consensus was reached on each of six topics, including “management of antiplatelet and anticoagulation drug therapy”; “pain control in the perioperative period”; “arterial embolization combined with ablation therapy”; “protection of non-target organs”; “RFA and cryoablation protocols”; and “ablative margins.”
Conclusions
The consensus achieved here will serve as the framework for tumor ablation therapies in Japan.
Similar content being viewed by others
References
Ye X, Fan W, Chen JH, Feng WJ, Gu SZ, Han Y, et al. Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer. 2015;6(1):112–21.
Yamanaka T, Yamakado K, Yamada T, Fujimori M, Takaki H, Nakatsuka A, et al. CT-guided percutaneous cryoablation in renal cell carcinoma: factors affecting local tumor control. J Vasc Interv Radiol: JVIR. 2015;26(8):1147–53.
Nakatsuka A, Yamakado K, Uraki J, Takaki H, Yamanaka T, Fujimori M, et al. Safety and clinical outcomes of percutaneous radiofrequency ablation for intermediate and large bone tumors using a multiple-electrode switching system: a phase II clinical study. J Vasc Interv Radiol: JVIR. 2015.
Kumasaka S, Miyazaki M, Tsushima Y. CT-guided percutaneous cryoablation of an aggressive osteoblastoma: a case report. J Vasc Interv Radiol: JVIR. 2015;26(11):1746–8.
Yamakado K, Matsumine A, Nakamura T, Nakatsuka A, Takaki H, Matsubara T, et al. Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol. 2014;19(5):955–62.
Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, et al. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol. 2013;18(1):46–53.
Iguchi T, Inoue D, Yabushita K, Sakaguchi K, Tatsukawa M, Sasaki H, et al. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung. Br J Radiol. 1016;2012(85):e373–7.
Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol: JVIR. 2012;23(1):48–54.
Miyazaki M, Aoki J, Miyazaki A, Nakajima T, Koyama Y, Shinozaki T, et al. Percutaneous radiofrequency ablation of osteoid osteoma using cool-tip electrodes without the cooling system. Jpn J Radiol. 2011;29(2):138–43.
Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231(3):850–7.
Yamakado K, Nakatsuka A, Akeboshi M, Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol: JVIR. 2003;14(9 Pt 1):1183–6.
Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontieres meeting 2013. Eur Radiol. 2015;25(12):3438–54.
Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol: JVIR. 2014;25(11):1691–705, e4.
Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200(3):658–64.
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.
Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.
Guidelines for the management of anticoagulant and antiplatelet therapy in patients with cardiovascular diseases. Japanese Circulation Society. 2009.
Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc. 2007;138(5):652–5.
Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62(8):1217–20.
Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e89S–119S.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med. 2009;361(12):1139–51.
Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. New Engl J Med. 2015;373(9):823–33.
de Baere T. Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Interv Radiol. 2011;34(2):241–51.
Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.
Sofocleous CT, Sideras P, Petre EN. “How we do it”—a practical approach to hepatic metastases ablation techniques. Tech Vasc Interv Radiol. 2013;16(4):219–29.
Yokoyama K, Ikeda O, Kawanaka K, Nakasone Y, Inoue S, Tamura Y, et al. Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation: comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery. Acta Radiol. 2014;55(10):1219–25.
Kang TW, Rhim H, Lee MW, Kim YS, Choi D, Lee WJ, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. AJR Am J Roentgenol. 2011;196(4):907–13.
Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Interv Radiol. 2008;31(1):122–30.
Gazzera C, Fonio P, Faletti R, Dotto MC, Gobbi F, Donadio P, et al. Role of paravertebral block anaesthesia during percutaneous transhepatic thermoablation. Radiol Med (Torino). 2014;119(8):549–57.
Hiraki T, Gobara H, Shibamoto K, Mimura H, Soda Y, Uka M, et al. Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases. J Vasc Interv Radiol: JVIR. 2011;22(4):503–6.
Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation—initial observations. Radiology. 2005;237(1):366–70.
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.
Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, et al. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32(4):242–50.
Yamanaka T, Yamakado K, Takaki H, Nakatsuka A, Shiraki K, Hasegawa H, et al. Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas. Jpn J Radiol. 2012;30(7):553–9.
Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol: JVIR. 2005;16(6):849–56.
Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20(29):10174–82.
Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19(24):3872–82.
Rhim H, Lee MH, Kim YS, Choi D, Lee WJ, Lim HK. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol. 2008;190(5):1324–30.
Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, et al. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44(5):374–80.
Chen JX, Guzzo TJ, Malkowicz SB, Soulen MC, Wein AJ, Clark TW, et al. Complication and readmission rates following same-day discharge after percutaneous renal tumor ablation. J Vasc Interv Radiol: JVIR. 2016;27(1):80–6.
Miller JM, Julien P, Wachsman A, Van Allan RJ, Friedman ML. The role of embolization in reducing the complications of cryoablation in renal cell carcinoma. Clin Radiol. 2014;69(10):1045–9.
Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):72–80.
Campbell C, Lubner MG, Hinshaw JL, Munoz del Rio A, Brace CL. Contrast media-doped hydrodissection during thermal ablation: optimizing contrast media concentration for improved visibility on CT images. AJR. Am J Roentgenol. 2012;199(3):677–82.
Hasegawa T, Takaki H, Miyagi H, Nakatsuka A, Uraki J, Yamanaka T, et al. Hyaluronic acid gel injection to prevent thermal injury of adjacent gastrointestinal tract during percutaneous liver radiofrequency ablation. Cardiovasc Interv Radiol. 2013;36(4):1144–6.
Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685.
Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171–5.
Inoue M, Nakatsuka S, Jinzaki M. Cryoablation of early-stage primary lung cancer. BioMed Res Int. 2014;2014:521691.
Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–90.
Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30(4):381–400.
Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Interv Radiol. 2013;36(3):783–90.
Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. Radiology. 2011;261(2):375–91.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Additional information
On behalf of Japan Image-guided Ablation Group.
About this article
Cite this article
Miyazaki, M., Iguchi, T., Takaki, H. et al. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Jpn J Radiol 34, 647–656 (2016). https://doi.org/10.1007/s11604-016-0569-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-016-0569-8